Our biomarker study demonstrates that CSF-1R expression on tumor-associated macrophages does not provide prognostic value; however, it is likely that in vivo CSF-1R expression on both the carcinoma cells and host macrophages contributes to the pharmacologic effects of inhibitors. Here, CSF1R is linked to neoplasm.